4.8 Article

Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack

Related references

Note: Only part of the references are listed.
Article Oncology

Immunometabolic Interplay in the Tumor Microenvironment

Irem Kaymak et al.

Summary: The study discusses the metabolic characteristics of immune cells in the tumor microenvironment and proposes future research directions.

CANCER CELL (2021)

Article Cell Biology

Di-methylation of CD147-K234 Promotes the Progression of NSCLC by Enhancing Lactate Export

Ke Wang et al.

Summary: CD147, methylated to CD147-K234me2 by KMT5A, plays a critical role in cancer metabolism by enhancing glycolysis and lactate export in NSCLC cells. High CD147-K234me2 expression is significantly related to cancer progression and overall survival in NSCLC patients, especially those in early stages, suggesting it as a promising therapeutic target.

CELL METABOLISM (2021)

Article Cell Biology

The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure

Ahmad A. Cluntun et al.

Summary: The metabolic rewiring of cardiomyocytes, including decreased mitochondrial pyruvate oxidation and increased lactate export, is a key feature of heart failure. The mitochondrial pyruvate carrier (MPC) and the cellular lactate exporter monocarboxylate transporter 4 (MCT4) play pivotal roles in this metabolic axis. Alteration of the pyruvate-lactate axis is a fundamental and early feature of cardiac hypertrophy and failure.

CELL METABOLISM (2021)

Review Cell Biology

NF-κB and mitochondria cross paths in cancer: mitochondrial metabolism and beyond

Daria Capece et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)

Review Endocrinology & Metabolism

Monocarboxylate transporters in cancer

Valery L. Payen et al.

MOLECULAR METABOLISM (2020)

Article Multidisciplinary Sciences

Metabolic heterogeneity confers differences in melanoma metastatic potential

Alpaslan Tasdogan et al.

NATURE (2020)

Review Pharmacology & Pharmacy

Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease

Melanie A. Felmlee et al.

PHARMACOLOGICAL REVIEWS (2020)

Article Multidisciplinary Sciences

Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8+ T cell stemness and antitumor immunity

Dalton Hermans et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Cell Biology

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

Helmut Sies et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Article Medicine, General & Internal

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Immunology

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Alex D. Waldman et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Oncology

Navigating metabolic pathways to enhance antitumour immunity and immunotherapy

Xiaoyun Li et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Review Biochemistry & Molecular Biology

Lactate: A Metabolic Driver in the Tumour Landscape

Luigi Ippolito et al.

TRENDS IN BIOCHEMICAL SCIENCES (2019)

Article Biochemistry & Molecular Biology

Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments

Yasna Contreras-Baeza et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Review Immunology

Metabolic interventions in the immune response to cancer

David O'Sullivan et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Article Gastroenterology & Hepatology

Loss of PDK4 switches the hepatic NF-B/TNF pathway from pro-survival to pro-apoptosis

Jianguo Wu et al.

HEPATOLOGY (2018)

Review Cell Biology

ROS signalling in the biology of cancer

Jennifer N. Moloney et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)

Article Oncology

Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer

Tilman Todenhoefer et al.

MOLECULAR CANCER THERAPEUTICS (2018)

Review Immunology

NF-κB, inflammation, immunity and cancer: coming of age

Koji Taniguchi et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Letter Medicine, General & Internal

Tumor Mutational Burden and Response Rate to PD-1 Inhibition

Mark Yarchoan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Oncology

Mitochondrial ROS control of cancer

Maria del Pilar Sosa Idelchik et al.

SEMINARS IN CANCER BIOLOGY (2017)

Review Cell Biology

The Emerging Hallmarks of Cancer Metabolism

Natalya N. Pavlova et al.

CELL METABOLISM (2016)

Article Biochemistry & Molecular Biology

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

Chih-Hao Chang et al.

Article Medicine, General & Internal

Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer

Edward B. Garon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Caroline Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)